Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Hormonal and Radiotherapy in High-Risk Prostate Cancer
NCT00349557Phase 2Completed
- Sponsor
- Benaroya Research Institute
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in prostate cancer (PCa), sponsored by Benaroya Research Institute. Started Apr 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00349557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349557.